Akcea Therapeutics Inc. (Nasdaq: AKCA) reported a greater than expected loss for the fourth quarter sending the stock price plunging $5.78 to close at $16.80.
Greater than expected loss for Akcea Therapeutics
February 27, 2018 at 17:03 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|